Took a few off on NOG @ 1.25 and BLRK @ 1.85. BLRX has a 70% margin requirement. Crazy!!
Watching MBRX, COVID news this morning (pumpish but shows potential).
Soligenix to Present at the MedInvest Infectious Disease and Immunology Investor Conference
PR NewswireJune 9, 2020
PRINCETON, N.J., June 9, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Senior Vice President and Chief Scientific Officer, Oreola Donini, PhD, will deliver a presentation discussing Soligenix's vaccine efforts, including a COVID-19 vaccine development program, at the MedInvest Infectious Disease and Immunology Investor Conference, held virtually on June 15 and 16, 2020.
Thermostabilized Protein Vaccines with Applications in Ricin Toxin, Filoviruses and Coronaviruses presented by Oreola Donini, PhD, Chief Scientific Officer, Soligenix on June 16 at 2:30 PM EDT. A question and answer period will follow the presentation.
A recording of the presentation will be available on the Soligenix website after June 16.
For more information about the MedInvest Infectious Disease and Immunology Investor Conference, please refer to the conference website at https://www.medinvestconferences.com